Global Delivering Technical Assistance 2 (DELTA2) Project
Overview
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a recognized leader in the global effort to eliminate pediatric AIDS and one of the most successful international implementation organizations for pediatric, adolescent, youth, and adult HIV prevention, care, and treatment programs. Through support from the U.S. government, as well as private and multilateral donors, EGPAF employs a comprehensive and sustainable approach to achieving the elimination of pediatric HIV, working at multiple levels of the healthcare system to meet the needs of women, children, adolescents, and families living with or affected by HIV. EGPAF currently provides TA at the national, sub-national, facility, and community levels in 17 countries to effectively support the implementation, scale-up, and evaluation of HIV, TB, and COVID-19 programs. EGPAF is able to provide high-impact, high-quality, innovative, contextually-responsive technical assistance (TA) across a wide range of areas including health system strengthening, strategic information and evaluation, digital health, operational research, quality improvement, community engagement, local organization capacity building and development, innovation/emerging technical priorities, project management, and HIV/TB/COVID-19 service delivery.
Project Overview
Through funding from the U.S. Centers for Disease Control and Prevention (CDC), EGPAF started implementing the five-year Delivering Technical Assistance 2 (DELTA2) cooperative agreement for global TA in HIV and AIDS in FY19 and is now in our fourth year of implementation. Building on EGPAF’s successful Project DELTA (2013–2019), DELTA2 provides TA services to optimize the impact of programs supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria to ultimately help achieve an AIDS-free generation. Through the original Project DELTA, EGPAF completed 37 assignments across 10 countries: Cameroon, Côte d’Ivoire, Lesotho, Malawi, Mozambique, Namibia, Tanzania, Uganda, Zambia, and Zimbabwe. In the initial three years of DELTA2, EGPAF and partners supported a variety of activities under PEPFAR’s Faith and Community Initiative including the development and dissemination of HIV and COVID-19 Messages of Hope for faith leaders and communities; conducted COVID-19 infection prevention and control studies in Cameroon, Cote d’Ivoire, Kenya, South Africa, and Uganda; established a Project ECHO telementoring platform in Haiti; and implemented No Means No dual gender violence prevention programming in five countries. EGPAF is also providing tailored TA to C19RM activities in six countries, is implementing the Violence Against Children Study in Jamaica and providing pediatric HIV and PMTCT TA in five states in Nigeria.
Andrea Uehling
Cameroon; Côte d’Ivoire; Lesotho; Malawi; Mozambique; Namibia; Tanzania; Uganda; Zambia; Zimbabwe
Cervical Cancer; COVID-19; Family Planning; HIV Treatment Optimization; Pediatric HIV Diagnosis, Care & Treatment; Strengthening Local Capacity; Tuberculosis